Neurocrine Biosciences, Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
|
|
|
|||
|
|||||
|
|
 
 |
return to message board, top of board |
Schadenfreude,As we watch the stock price sink with few catalysts on the horizon, I take perverse pleasure in the fact that the last batch of option grants was priced at $8.60. The enjoyments of masochism aside, I would just as soon have them in the money. Have a good weekend everyone. Ochs
|
|
|
return to message board, top of board |
